A Rule Without a Sheriff

The American Veterinary Medical Association has been unambiguous on the question of fee-splitting for decades. Its Principles of Veterinary Medical Ethics state it plainly: a veterinarian shall not offer or receive any financial incentive solely for the referral of a patient. The AVMA defines fee-splitting as payment by a receiving veterinarian of part of their fee to a referring veterinarian who has not rendered professional services — and classifies it as unethical regardless of the amount, regardless of the arrangement’s label, and regardless of what the parties call it in their contracts.

In 2011, the AVMA Executive Board sharpened the language — and the circumstances that prompted the revision are instructive. In 2010, during active litigation over an alleged veterinary teleradiology kickback scheme, the defendant company sought a formal AVMA opinion on whether its arrangement constituted fee-splitting under the existing Principles. The AVMA’s response under the pre-2011 language was that it did not. The following year, the AVMA Judicial Council revised the Principles, acknowledging in its own published explanation that the original language “may not have been in keeping with contemporary veterinary practice.” The Judicial Council chair explained the core rationale: fee-splitting is unethical because it involves a veterinarian receiving financial compensation for services they did not render or dispense.

The 2011 revision introduced a carveout that requires careful reading. The use of consultants, laboratory services, and online pharmacies does not constitute fee-splitting — because in those arrangements the third party is rendering a service or supplying a product directly, independently, and transparently. A laboratory processing a blood panel is not in a referral relationship with the practice. An online pharmacy dispensing a prescription is not receiving a patient referral fee. These are arms-length commercial transactions, not referral incentive structures.

A board-certified veterinary radiologist providing a teleradiology interpretation is an entirely different category. The radiologist is a specialist rendering a professional medical judgment — the same category of professional service as a referral to a specialty hospital. When a financial arrangement layers a referral incentive on top of that professional relationship — routing cases to a particular radiologist or teleradiology service in exchange for financial benefit flowing back to the referring party, or marking up the specialist’s fee without disclosure to the client — the consultant carveout does not apply. That is precisely the conduct the prohibition was written to address. The 2011 revision clarified the distinction between legitimate consulting arrangements and impermissible referral incentive structures. It did not create a loophole for the latter.

The Perverse Incentive the Rule Was Written to Prevent

The fee-splitting prohibition is not an abstract ethics rule. It exists because of a specific, predictable harm: when a referring veterinarian profits from the spread between what a specialist charges and what the client is billed, the financial incentive runs directly against the patient’s clinical interest.

Consider the arithmetic. A clinic charges a pet owner $200 for a radiology consultation. That flat fee appears on the invoice as a single line item. The teleradiology service the clinic uses charges the clinic $40 per case. The clinic keeps $160. Now consider what happens when that same clinic is evaluating which teleradiology service to use next year. The service charging $40 delivers the largest margin. The service charging $120 — staffed by more experienced radiologists, with faster turnaround and more detailed reports — delivers a smaller one. The financial incentive is to select the cheapest radiologist, not the best one. The pet owner, seeing only a single line item, has no way to know that any portion of the $200 “diagnostic services” fee was retained by the referring clinic rather than paid to a diagnostician.

This is precisely why the federal anti-kickback statute exists in human medicine, and precisely why state veterinary fee-splitting prohibitions exist. The law is not paternalistic about business arrangements — it is severing a specific incentive structure that predictably degrades clinical decision-making. When the referring party’s financial interest and the patient’s clinical interest point in opposite directions, the law intervenes. The fee-splitting prohibition is that intervention.

The AVMA’s consultant carveout does not change this analysis. The carveout applies to arrangements where the third party is rendering an independent professional service at a disclosed rate — analogous to a reference laboratory charging a posted price per test. It does not apply when the referring practice is marking up a specialist’s fee without client disclosure and retaining the spread as profit. That is the arrangement the prohibition was written to address. The label attached to it — “radiology consultation,” “telemedicine fee,” “diagnostic service” — is irrelevant. The economic structure is what the statute examines.

Several states have gone further and codified the prohibition into law. No state Attorney General has yet issued a formal opinion drawing the line between permissible referral incentives and illegal fee-splitting in a veterinary context. That opinion vacuum is not an accident — it is, for the companies that benefit from the ambiguity, an asset.

And yet the practice is widespread. It is embedded in corporate consolidator business models. It flows through PACS integration agreements, exclusive imaging contracts, diagnostic platform arrangements, and referral network structures that have become standard features of the corporate veterinary landscape. It operates in plain sight, at scale, essentially unenforced.

This is the story of a profession that wrote the ethics rule, watched the states begin writing the laws, and is now waiting — apparently indefinitely — to see who blinks first.

What the Rule Actually Says

The AVMA’s Principles of Veterinary Medical Ethics are the foundational professional conduct standard for the veterinary profession in the United States. Every state veterinary medical board references them. Professional organizations are explicitly encouraged to adopt them or a similar code as a guide for their activities. They are not aspirational suggestions — they are the baseline standard of professional conduct against which veterinary license holders are measured.

On fee-splitting, the Principles are structured in three layers. First, the definition: fee-splitting is payment by a receiving veterinarian of part of their fee to a referring veterinarian who has not rendered professional services. Second, the prohibition: a veterinarian shall not offer or receive any financial incentive solely for the referral of a patient. Third, the conflict of interest framework: a veterinarian shall not allow financial interests to influence the choice of treatment or animal care, and shall consider the potential for conflict of interest when deciding whether to participate in vendor incentive programs or other arrangements where the veterinarian receives a benefit for using or prescribing a particular product.

That third layer is where the corporate veterinary consolidation model runs directly into the ethics code. When a diagnostic imaging platform is bundled with a referral relationship, when a PACS integration agreement creates financial incentives tied to routing cases to a particular service, when a teleradiology contract is structured to reward volume rather than quality — the AVMA Principles are not silent on these arrangements. They address them directly. They classify them as ethically impermissible.

The question is not whether the rule covers these arrangements. It does. The question is who enforces it — and the answer, in practice, is almost no one.

Where the Law Has Spoken

The statutory landscape is more extensive than the profession’s public discussion suggests. Fee-splitting prohibitions applicable to veterinary practice appear in three distinct bodies of law: dedicated veterinary practice acts, general health occupations codes that apply across all licensed health professions including veterinary medicine, and general anti-kickback provisions that apply to any health care provider. Understanding which category a state’s prohibition falls into matters — because the scope, the enforcement mechanism, and the available penalties differ significantly across all three.

Category One: Veterinary Practice Acts

Several states have embedded fee-splitting prohibitions directly in the statutory chapter that governs the practice of veterinary medicine. These provisions are administered by state veterinary medical boards and violations are grounds for license discipline.

Category Two: Health Occupations Codes — Cross-Profession Application

A second and often-overlooked category of prohibition comes from general health occupations codes that apply across all licensed health professions — including veterinary medicine. These are not veterinary-specific statutes. They were written to govern physicians, dentists, pharmacists, and other licensed practitioners, but their language is broad enough to encompass veterinarians practicing in the same state. In some cases, state regulators and courts have confirmed this application explicitly.

Category Three: General Anti-Kickback Statutes

A third body of law — general anti-kickback statutes applicable to all healthcare providers — extends fee-splitting prohibitions well beyond the narrow category of licensed professional codes. Florida’s Chapter 456 kickback prohibition, for example, applies broadly to any “health care provider” and prohibits offering, paying, soliciting, or receiving kickbacks for referring patients. Though veterinary medicine sits in a separate statutory chapter in Florida (Chapter 474 rather than Chapter 456), the overlap between these frameworks has produced interpretive questions in multiple states that courts and regulators have not fully resolved.

The significance of general anti-kickback statutes for veterinary practice is that they often carry criminal penalties in addition to professional sanctions. Violations of Florida § 456.054 are unlawful — the statute uses that word — with consequences that extend beyond license discipline into potential criminal prosecution and civil liability.

The multi-state picture reveals a regulatory landscape far more developed than the industry’s public posture suggests. Texas, Nevada, Pennsylvania, Florida, New York, and California each have statutory or regulatory provisions that reach veterinary referral incentive structures in one form or another. They differ in scope, in enforcement mechanism, and in the availability of disclosure exceptions — but together they establish that fee-splitting in veterinary practice is not a regulatory gray area in the United States. It is a regulated area with specific statutory language, specific enforcement mechanisms, and specific penalties. The gap is not in the law. The gap is in enforcement.

And enforcement will arrive. The trajectory of the regulatory landscape makes that clear.

The Fourteen-State Signal

In the mid-2010s, a veterinary medication home-delivery company called VetSource built a successful business routing prescription medications directly to pet owners on behalf of veterinary practices. The model proved popular — popular enough that fourteen state pharmacy boards simultaneously initiated investigations into whether VetSource’s arrangements with veterinary practices violated state anti-kickback statutes.

The fourteen states were California, Colorado, Illinois, Iowa, Maryland, Michigan, Minnesota, Nevada, Oregon, Pennsylvania, South Carolina, Texas, Virginia, and Wisconsin. Nevada’s pharmacy board sent letters asserting that VetSource’s business model violated the state’s anti-kickback statute directly.

VetSource ultimately prevailed. The Nevada complaint was rescinded. The company continues to operate. But the significance of the episode is not the outcome — it is the breadth and simultaneity of the regulatory response. Fourteen state pharmacy boards, acting independently, reached the same conclusion: that the anti-kickback logic they applied to their own licensees extended to veterinary practice contexts. They were wrong, in that specific case, on the specific legal theory they pursued. But the appetite to apply anti-kickback frameworks to veterinary medicine was real, it was widespread, and it was coordinated enough to produce simultaneous multi-state action.

What the VetSource episode proved is that the regulatory machinery exists. Anti-kickback statutes are on the books. State boards are willing to invoke them in veterinary contexts. The question that remains unanswered — the question no state AG has yet addressed — is precisely where the line falls between a permissible business arrangement and an illegal kickback when the parties involved are veterinarians, corporate platforms, and referral networks rather than pharmacy boards and home-delivery companies.

That is not a reassuring ambiguity for the industry. It is an open question that a single aggressive enforcement action could answer definitively — and retroactively — for every corporate consolidator that has been operating in the gap.

What Corporate Consolidation Has Built in That Gap

The fee-splitting prohibition exists precisely because referral incentives corrupt clinical judgment. When a veterinarian receives financial benefit for routing a patient to a particular service, the clinical decision is no longer made solely on the basis of the patient’s needs — it is made at least in part on the basis of the referring veterinarian’s financial interest. The AVMA identified this problem and prohibited it. Three states codified the prohibition. The profession’s ethics infrastructure was designed to prevent exactly this outcome.

What corporate veterinary consolidation has built in the years since those rules were written is a landscape in which referral incentive structures are not the exception — they are the architecture. Diagnostic imaging platforms bundled with practice management systems create switching costs that function as de facto referral locks. Exclusive teleradiology contracts route cases to affiliated services regardless of clinical suitability. PACS integration agreements that favor proprietary networks create financial incentives to keep cases within a corporate ecosystem. Per-case fee structures that reward volume create pressure to refer more, not to refer better.

None of these arrangements are called kickbacks. None of them are disclosed to clients as referral incentive structures. All of them produce the outcome the AVMA’s fee-splitting prohibition was written to prevent: clinical decisions influenced by financial relationships that the patient’s owner does not know exist.

The legal commentators who track this area have been consistent in their assessment. As Frier Levitt, a healthcare law firm with veterinary practice expertise, has noted: most states have enacted statutes and regulations that broadly prohibit referral arrangements resulting in any rebate, refund, commission, discount, or other consideration as compensation for referring clients — and these prohibitions often encompass health care-related professions including veterinary practice. Penalties frequently include imprisonment in addition to substantial fines.

The industry has been operating as if those penalties are theoretical. The regulatory trajectory suggests they are not.

The AG Opinion Vacuum — and What Fills It

No state Attorney General has issued a formal opinion specifically addressing veterinary fee-splitting, kickbacks, or referral incentive structures in a veterinary teleradiology or corporate consolidation context. This is the single most consequential gap in the current regulatory landscape — and it cuts in both directions.

For companies operating referral incentive structures, the absence of an AG opinion provides a degree of cover: there is no definitive ruling saying what they are doing is illegal. For regulators and advocates seeking to challenge those structures, the absence of an opinion represents an open invitation: the question has not been asked in the right forum yet.

AG opinions typically emerge from one of three sources: a complaint filed by a affected party, a referral from a state licensing board, or a legislative inquiry. All three pathways are available in the current environment. A veterinary practice that believes it has been harmed by a corporate consolidator’s referral incentive structure has standing to file a complaint in Texas, Nevada, or Pennsylvania today. A state veterinary medical board that receives credible evidence of fee-splitting has authority to refer the matter to the AG. A state legislator representing rural veterinary markets that have been foreclosed by exclusive corporate contracts has every incentive to ask the question formally.

The opinion vacuum will eventually be filled. The only open questions are when, in which state, and which company’s business model will be the one that gets examined first.

The AVMA’s Unenforced Rule and What It Means for the Profession

The AVMA’s fee-splitting prohibition has been on the books for decades. The 2011 revision sharpened it. The 2017 House of Delegates discussion reaffirmed it — delegates concluded that the existing Principles were sufficient to address transparency in vendor incentive programs without additional guidelines being necessary. The profession has looked at this issue multiple times and reached the same conclusion each time: the rule is clear, it covers the conduct in question, and no additional rulemaking is required.

What the profession has not done is enforce it at scale against corporate entities operating referral incentive structures. The AVMA’s enforcement mechanism runs through state ethics committees and state licensing boards — individual-level proceedings against individual license holders. It was not designed to address corporate platforms that structure referral incentives at the system level, across thousands of practices, in ways that no individual veterinarian may be able to identify as a violation.

This is the structural gap between the ethics rule and the current industry reality. The AVMA prohibited the conduct. The states are beginning to codify the prohibition. The enforcement infrastructure — built for individual professional misconduct — has not yet been adapted to address systemic corporate conduct. Until it is, the gap between what the rules say and what the industry does will remain exactly what it has been: a business model.

The VCPR Carveout: How a Clinical Concept Became a Financial Shield

The most consequential — and most troubling — element of the AVMA’s 2011 revision was not what it prohibited. It was what it quietly permitted. Buried in the revision was a structural distinction built on the veterinarian-client-patient relationship, or VCPR, that effectively carved teleradiology out of the fee-splitting prohibition entirely.

The AVMA’s published explanation of the 2011 changes described it directly: because the use of a consulting veterinarian does not create a new veterinarian-client-patient relationship, collection of a fee by the attending veterinarian from the client for the consultation would not be considered fee-splitting. The attending veterinarian, under this logic, may collect the client’s money, pay the teleradiologist a wholesale rate, retain the markup as practice revenue, and charge the client a single opaque line item — and the AVMA has ruled this arrangement does not constitute fee-splitting. The reason: the teleradiologist never examines the animal and therefore never establishes a VCPR.

The VCPR is a legitimate and important clinical concept. It defines the legal and professional basis for veterinary prescribing authority, medical recordkeeping obligations, and the scope of the veterinarian’s duty of care to the patient. It was designed to ensure that veterinary medical decisions are made by practitioners with direct knowledge of the animal and accountability to the client. It was never designed, in any statutory or regulatory context, to determine whether a financial markup constitutes a referral kickback.

The AVMA imported a clinical relationship concept into a financial conduct analysis and used it to carve out precisely the arrangement the prohibition was written to prevent. The result is a rule that prohibits fee-splitting when a patient is sent to a referral specialist — because a VCPR is established — but permits an attending veterinarian to profit from an undisclosed markup on a teleradiologist’s work, because no VCPR is established. The clinical distinction is real. Its application to financial conduct analysis is invented.

Consider the parallel in human medicine. When a hospital physician orders a radiology study, the radiologist who reads it bills independently. The ordering physician does not collect the radiology fee, mark it up, and charge the patient a single undifferentiated line item that conceals the radiologist’s actual charge. The radiologist generates a separate bill. The patient receives separate explanation of benefits. The ordering physician has no financial interest in which radiologist reads the film or what that radiologist charges. This is not a product of any VCPR-equivalent concept in human medicine. It is a billing transparency and consumer protection standard enforced by payers, regulators, and law — entirely independent of the clinical relationship framework.

The AVMA’s VCPR carveout produced the opposite outcome for veterinary teleradiology: a framework in which the attending practice has both the opportunity and the financial incentive to intermediate the teleradiologist’s fee, conceal the markup from the client, and profit from the spread — with the AVMA’s own ethics code providing cover for doing so. The pet owner receives one invoice line. The attending practice retains the difference. The teleradiologist who actually performed the diagnostic work is paid wholesale. None of this is disclosed. And under the AVMA’s 2011 interpretation, none of it is fee-splitting.

What State Practice Acts Actually Say: Diagnosis Is Practice, With or Without a VCPR

The AVMA’s VCPR carveout rests on a specific legal assumption: that because a teleradiologist does not establish a VCPR with the patient, the fee paid for the teleradiologist’s work is not a fee for the practice of veterinary medicine — and therefore the attending clinic’s markup of that fee is not fee-splitting between veterinary practitioners.

That assumption is contradicted by the plain statutory text of every major state veterinary practice act. Every state structures its veterinary practice law the same way: it defines “the practice of veterinary medicine” in one section, and it defines the VCPR as a separate clinical relationship concept in another. The definition of practice is not limited by VCPR. It is defined independently. And in every state examined, making a diagnosis constitutes the practice of veterinary medicine — full stop, without reference to whether a VCPR exists.

Texas Occupations Code § 801.002(5) defines “practice of veterinary medicine” as “the diagnosis, treatment, correction, change, manipulation, relief, or prevention of animal disease, deformity, defect, injury, or other physical condition.” The VCPR is defined separately, in § 801.351, as a clinical relationship governing the veterinarian’s ongoing responsibility to the patient. The definition of practice does not incorporate the VCPR. It stands alone. A teleradiologist reading a radiograph and issuing a diagnostic interpretation is, under the plain text of § 801.002(5), practicing veterinary medicine in Texas — regardless of whether a VCPR is established.

Florida § 474.202(9) defines “practice of veterinary medicine” as “diagnosing the medical condition of animals.” That is the first and primary element of the definition. The VCPR is defined separately in § 474.202(12). And Florida goes further than any other state on this point: § 474.202(13) explicitly names radiology as a branch or specialty of veterinary medicine. Florida statute directly and unambiguously names what a teleradiologist does — radiology — as a component of veterinary medicine. When a teleradiologist reads a radiograph and issues a diagnostic report for a Florida patient, they are practicing a named branch of veterinary medicine under Florida statute. The absence of a VCPR does not change this. The definition section does not require one.

California Business and Professions Code § 4826 defines the practice of veterinary medicine to include anyone who “diagnoses or prescribes a drug…for the prevention, cure, or relief of a wound, fracture, bodily injury, or disease of animals.” Diagnosis alone, without prescription, without treatment, without any ongoing clinical relationship — constitutes practice of veterinary medicine under California law. A teleradiologist who issues a diagnostic interpretation and nothing else has practiced veterinary medicine in California as a matter of statutory definition.

Pennsylvania’s Veterinary Medicine Practice Act defines practice to include anyone who “diagnoses, treats, corrects, changes, relieves or prevents animal disease…by any method or mode, including the prescription or administration of any drug…or other therapeutic or diagnostic substance or technique.” The phrase “diagnostic substance or technique” is particularly significant: the imaging study that a teleradiologist interprets is a diagnostic technique. North Carolina, Utah, and the substantial majority of states with explicit statutory definitions use substantially identical language — diagnosis is practice, without VCPR qualification.

The legal consequence is direct and cannot be resolved by reference to the AVMA’s 2011 revision. The fee that a teleradiology company charges for its diagnostic work is a fee for the practice of veterinary medicine — as defined by state statute, not as defined by the AVMA’s internal ethics code. When an attending clinic collects that fee from the client, marks it up, retains the difference, and pays the teleradiologist a wholesale rate without client disclosure, the clinic is splitting a fee with another practitioner of veterinary medicine. That is precisely what the fee-splitting statutes prohibit.

The AVMA’s VCPR carveout carved around the wrong concept. VCPR determines whether the teleradiologist can prescribe drugs, establish an ongoing treatment relationship, or be held independently responsible for the patient’s care. It was never designed to determine whether the act of diagnosis constitutes the practice of veterinary medicine. State legislatures determined that — in the definition sections of their practice acts — and they determined it without any VCPR qualification whatsoever.

How One Major Public Company Responded to This Exact Problem

If the AVMA’s VCPR carveout actually resolved the regulatory exposure — if the absence of a VCPR genuinely meant that teleradiology services were not the practice of veterinary medicine, and therefore not subject to fee-splitting analysis — there would be no reason for a company to disclaim, in its contracts, that it is making a diagnosis. The disclaimer would be unnecessary. The exposure it is designed to address would not exist.

IDEXX Laboratories, a publicly traded company with approximately $3.9 billion in annual revenue and the largest veterinary diagnostics market position in the world, does not appear to believe the VCPR carveout resolves the exposure. Its published Master Terms — specifically Section 9.2.3 of the IDEXX General Terms, which has appeared unchanged across at least two consecutive revision cycles — contain the following disclaimer covering its teleradiology and telemedicine consulting services: the company’s Clinical Content, including patient-specific test result interpretive assistance, “does not constitute an opinion, medical advice, diagnosis, or recommended procedure or treatment of any particular medical condition.” The Telemedicine Offering Specific Terms add a “Notice to Veterinarians” reinforcing the point: “IDEXX does not purport to diagnose or treat your patient.” The Limit of Liability caps IDEXX’s total financial exposure per study at the amount the clinic paid — $225 to $350 — regardless of the clinical consequences of a missed or incorrect interpretation.

Read against the statutory analysis above, this disclaimer reveals something important about how sophisticated legal counsel at a major public company actually assesses this risk. IDEXX’s marketing materials describe its radiology service as providing “detailed written interpretation” and its internal medicine service as providing a “detailed written treatment plan” — language that, under any state practice act’s definition, describes the practice of veterinary medicine. But the contract says the opposite: not a diagnosis, not medical advice, not a recommended procedure. The reason for this contradiction is not difficult to identify. IDEXX’s lawyers know what every state practice act says. They know that “diagnosis” constitutes practice of veterinary medicine in Texas, Florida, California, Pennsylvania, North Carolina, and every other state with an explicit statutory definition. They drafted the disclaimer because the regulatory exposure is real — and because the AVMA’s VCPR carveout does not eliminate it.

What the disclaimer accomplishes is not legal protection for IDEXX. It is liability transfer to the referring veterinarian. IDEXX collects the fee. IDEXX disclaims the diagnosis. The referring veterinarian holds the professional license, retains clinical responsibility for the outcome, and — in the majority of arrangements — marks up the teleradiology fee before charging the pet owner without disclosure. The AVMA’s carveout gave the industry a business model. IDEXX’s disclaimer gives the industry’s largest participant a contractual shield against the consequences of that model — while placing every element of regulatory and malpractice risk on the clinic that signed the terms. Whether that disclaimer would actually hold against a state veterinary board or a malpractice claim is a separate question, analyzed in detail in The IDEXX Ecosystem on this site. The point for this analysis is simpler: a $3.9 billion public company felt it necessary to disclaim, in writing, that its teleradiology service makes diagnoses. That is not the behavior of a company that believes the VCPR carveout has resolved the regulatory question. That is the behavior of a company that knows the question is unresolved — and is managing the exposure accordingly.

The Bank Robbers’ Association Opinion: A Study in Why Private Ethics Opinions Are Not Legal Shields

Consider a hypothetical. Suppose there existed a private membership organization — call it the American Association of Bank Robbers. The Association has thousands of dues-paying members. It has a code of ethics. It has a Judicial Council. It issues formal opinions on questions of professional conduct submitted by its members. And it has now issued a formal opinion stating that robbing banks on Saturdays is ethically permissible under the Association’s internal conduct standards, because banks are closed on Saturdays and therefore no tellers are directly inconvenienced by the transaction.

The question writes itself: would any defendant walk into federal court, hand the judge that opinion, and argue that membership in the American Association of Bank Robbers and reliance on its Saturday-robbery ethics ruling constitutes a legal defense to bank robbery charges?

Nobody would. No competent defense attorney would file that brief. No judge would receive it with anything other than incredulity. The reason is obvious to every person who has ever thought about how law works: a private organization’s internal ethics opinion does not create, modify, or supersede statutory law. It does not bind prosecutors. It does not bind courts. It is not a safe harbor. It is not a defense. It is a private organization’s opinion about its own internal standards — and its legal force begins and ends there.

The AVMA’s 2011 opinion on VCPR-exempt teleradiology markups is structurally identical to the Saturday bank robbery ruling. The AVMA is a private professional membership organization. It has no statutory authority, no regulatory jurisdiction, and no enforcement power in any state. Its Judicial Council opinions are not binding on any court, any licensing board, any Attorney General, or the Federal Trade Commission. The opinion that teleradiology markup arrangements do not constitute fee-splitting — because the teleradiologist does not establish a VCPR — does not modify Texas Occupations Code § 801.402(11). It does not create a safe harbor from Florida § 474.214(1)(k). It does not carve an exception into New York Education Law § 6509-a. It does not supersede California Business and Professions Code § 650. It does not constrain the FTC’s authority under 15 U.S.C. § 45.

The professional prestige of the AVMA, the sophistication of its Judicial Council process, and the earnestness with which the opinion was requested and issued are all entirely beside the point. Prestige does not make a private ethics opinion into law. Sophistication does not make an internal conduct ruling binding on a state licensing board. The American Association of Bank Robbers could hire the finest legal scholars in the country to craft its Saturday-robbery opinion — and it would still be worth exactly nothing in a federal courtroom.

What makes the veterinary teleradiology situation more troubling than the hypothetical is this: the companies relying on the AVMA opinion almost certainly know this. They have legal counsel. Their legal counsel knows that a private membership organization’s ethics opinion is not a statutory defense. They are not relying on the opinion because they believe it constitutes a legal shield. They are relying on it because it constitutes a business justification — a document they can point to when questions are raised, a professional imprimatur that discourages challenge, and a reason for regulators who have limited enforcement resources to look elsewhere. The opinion is not a defense. It is a deterrent to scrutiny. And it has worked — so far.

A Private Opinion Is Not a Legal Shield

The AVMA is a private professional membership organization. It has no statutory authority. It has no regulatory jurisdiction in any state. It cannot make law, enforce law, or interpret law in any forum with binding legal effect. Its Principles of Veterinary Medical Ethics are voluntary conduct guidelines that state licensing boards may choose to reference — but the AVMA cannot compel any state to adopt them, cannot grant any immunity from state or federal statute, and cannot shield any veterinarian or company from legal liability by issuing a favorable ethics opinion.

This matters enormously for the VCPR carveout. When the AVMA declared in 2011 that teleradiology markup arrangements do not constitute fee-splitting because no VCPR is established, it was not interpreting Texas Occupations Code § 801.402(11). It was not interpreting Nevada NRS § 638.1404. It was not interpreting Florida § 474.214(1)(k), New York Education Law § 6509-a, or California Business and Professions Code § 650. It was a private organization issuing internal ethics guidance that has no legal force whatsoever against any of those statutes — or against federal consumer protection law.

The Federal Trade Commission Act prohibits unfair or deceptive acts or practices in commerce. The FTC’s jurisdiction is not limited to human medicine and contains no general exemption for veterinary services. A veterinary practice that charges a pet owner $200 for “radiology consultation,” pays a teleradiologist $40, and retains $160 without disclosing the arrangement to the client is engaged in a potentially deceptive commercial practice under the plain meaning of the FTC Act: the consumer is paying for a service that is being materially misrepresented on the invoice. The AVMA’s opinion that this is not fee-splitting under its ethics code is entirely irrelevant to the FTC’s consumer protection analysis. The FTC does not defer to private professional association ethics opinions in enforcement proceedings. Neither do state Attorneys General. Neither do state veterinary licensing boards applying the plain text of their state’s statutes.

None of the state statutes documented in this article contain a VCPR exception. None of them contain an AVMA-opinion safe harbor. Texas § 801.402(11) prohibits remuneration for referring a client, period — without reference to whether a consulting or referral relationship exists, and without reference to what the AVMA has opined on the subject. Florida § 474.214(1)(k) prohibits kickbacks and remuneration for referring a patient, period. These are legislative enactments. They mean what they say. They are not subject to modification by a private membership organization’s internal ethics revision.

This raises the question that the veterinary teleradiology industry has not yet been forced to answer in any regulatory or judicial forum: who is willing to be the first to walk into a Texas licensing board disciplinary hearing, a state AG enforcement proceeding, or an FTC investigation and argue that the AVMA’s 2011 opinion provides a legal defense against a statutory violation?

The answer, almost certainly, is nobody with competent legal counsel. An AVMA ethics opinion is not a legal defense. It is not a safe harbor. It is not binding on any regulatory body, court, or enforcement agency. A company that has structured its teleradiology business model around the VCPR carveout — routing client fees through attending practices, retaining an undisclosed markup, and pointing to the AVMA’s ethics code as justification — has built its compliance posture on a foundation that has never been tested against the statutes that actually govern the conduct.

The consumers whose money flows through that arrangement — the pet owners paying $200 for a diagnostic service that cost the practice $40 — are the parties the law was written to protect. Not the AVMA’s membership. Not the corporate platforms that profit from the markup. The pet owner. And the pet owner’s legal interests are not served by a private professional association’s determination that the arrangement is ethically permissible under a clinical relationship framework that was never designed to address financial conduct.

The industry has been operating as though the AVMA’s opinion settles the question. It settles nothing. It is a private organization’s internal guidance — one that has never been tested in the forum where it would actually matter, against the statutes that would actually apply, before the regulators who would actually decide. When that test comes, the AVMA opinion will not be cited in the defendant’s favor. It will be cited by the plaintiff as evidence that the industry was on notice of the ethical problem, chose to rely on a non-binding carveout rather than address the underlying conduct, and continued operating a business model that extracted undisclosed profit from consumers while their own profession’s ethics code was flashing a warning light.